SUPPLEMENT

Q4 2021 — Income statement trends

Q4 2021PDF · 2 pages136 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q120 	Q220 	Q320 	Q420 	Q121 	Q221 	Q321 	Q421
Revenues:
Clearing and transaction fees 	1,278.8 	940.2 	835.4 	843.0 	1,007.0 	929.9 	878.9 	949.3
Market data and information services 	131.5 	134.7 	139.4 	139.8 	144.2 	145.2 	145.4 	142.1
Other Revenue 	111.8 	107.4 	105.9 	115.7 	102.1 	104.1 	85.6 	55.9
Total revenues 	1,522.1 	1,182.3 	1,080.7 	1,098.5 	1,253.3 	1,179.2 	1,109.9 	1,147.3
Expenses:
Compensation and benefits 	207.5 	217.0 	216.4 	215.6 	225.0 	211.7 	198.6 	201.7
Technology 	47.7 	49.1 	48.1 	53.6 	48.2 	49.3 	49.3 	45.8
Professional fees and outside services 	41.7 	51.2 	48.4 	50.0 	37.4 	36.8 	45.2 	32.3
Amortization of purchased intangibles 	77.3 	76.6 	78.3 	79.0 	60.6 	59.4 	59.0 	58.6
Depreciation and amortization 	35.3 	36.7 	39.7 	41.5 	37.6 	37.1 	37.2 	35.9
Licensing and other fee agreements 	73.9 	55.4 	57.7 	57.9 	64.7 	54.2 	57.6 	60.4
Other expense 	78.8 	58.8 	67.1 	85.9 	54.7 	56.0 	49.3 	80.9
Operating expenses 	562.2 	544.8 	555.7 	583.5 	528.2 	504.5 	496.2 	515.6
Operating Income 	959.9 	637.5 	525.0 	515.0 	725.1 	674.7 	613.7 	631.7
Operating Margin 	63% 	54% 	49% 	47% 	58% 	57% 	55% 	55%
Non-operating Income and Expense
Investment income 	95.9 	32.1 	23.6 	31.1 	30.9 	62.4 	145.8 	67.8
Interest and other borrowing costs 	(40.9) 	(41.9) 	(41.7) 	(41.7) 	(41.5) 	(41.7) 	(41.8) 	(41.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	51.2 	48.8 	44.0 	46.6 	56.2 	55.7 	66.4 	67.5
Other non-operating income (expense) 	(76.8) 	(15.2) 	(14.4) 	(16.0) 	(18.4) 	(25.0) 	311.8 	74.2
Non-operating income (expense) 	29.4 	23.8 	11.5 	20.0 	27.2 	51.4 	482.2 	167.6
Income before income taxes 	989.3 	661.3 	536.5 	535.0 	752.3 	726.1 	1,095.9 	799.3
Income taxes 	222.5 	158.0 	125.0 	110.2 	177.5 	215.5 	169.6 	174.1
Net income 	766.8 	503.3 	411.5 	424.8 	574.8 	510.6 	926.3 	625.2
Less: net income (loss) attributable to NCI 	0.6 	- 	(0.2) 	0.8 	0.4 	0.3 	(0.2) 	-
Net Income Attributable to CME Group 	766.2 	503.3 	411.7 	424.0 	574.4 	510.3 	926.5 	625.2
Net Income Attributable to Common Shareholders of CME Group 	766.2 	503.3 	411.7 	424.0 	574.4 	510.3 	926.5 	613.3
Effective Tax Rate 	22.5% 	23.9% 	23.3% 	20.6% 	23.6% 	29.7% 	15.5% 	21.8%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	2.14 	1.41 	1.15 	1.18 	1.60 	1.42 	2.59 	1.71
Diluted EPS 	2.14 	1.40 	1.15 	1.18 	1.60 	1.42 	2.58 	1.71
Weighted Average Number of Common Shares:
Basic Shares 	357,524 	357,691 	357,791 	358,047 	358,147 	358,261 	358,363 	358,582
Diluted Shares 	358,455 	358,457 	358,590 	358,612 	358,817 	358,888 	358,988 	359,019

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q120 	Q220 	Q320 	Q420 	Q121 	Q221 	Q321 	Q421
Revenues:
Clearing and transaction fees 	1,278.8 	940.2 	835.4 	843.0 	1,007.0 	929.9 	878.9 	949.3
Market data and information services 	131.5 	134.7 	139.4 	139.8 	144.2 	145.2 	145.4 	142.1
Other Revenue 	111.8 	107.4 	105.9 	115.7 	102.1 	101.0 	85.6 	55.9
Total revenues 	1,522.1 	1,182.3 	1,080.7 	1,098.5 	1,253.3 	1,176.1 	1,109.9 	1,147.3
Expenses:
Compensation and benefits 	210.9 	202.7 	205.5 	202.6 	207.5 	201.9 	191.1 	183.7
Technology 	47.3 	48.5 	47.3 	52.2 	47.7 	49.2 	49.1 	45.6
Professional fees and outside services 	35.3 	42.7 	40.0 	39.2 	27.9 	30.0 	26.5 	27.2
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	34.5 	33.7 	37.0 	37.2 	36.8 	36.7 	36.7 	35.6
Licensing and other fee agreements 	73.9 	55.4 	57.7 	57.9 	64.7 	54.2 	57.6 	60.4
Other expense 	57.6 	51.9 	56.1 	74.3 	52.1 	54.8 	51.3 	76.5
Operating expenses 	459.5 	434.9 	443.6 	463.4 	436.7 	426.8 	412.3 	429.0
Operating Income 	1,062.6 	747.4 	637.1 	635.1 	816.6 	749.3 	697.6 	718.3
Operating Margin 	70% 	63% 	59% 	58% 	65% 	64% 	63% 	63%
Non-operating Income and Expense
Investment income 	102.3 	26.4 	22.6 	24.1 	26.9 	37.3 	55.1 	58.2
Interest and other borrowing costs 	(42.6) 	(41.9) 	(41.7) 	(41.7) 	(41.5) 	(41.7) 	(41.8) 	(41.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	51.2 	48.8 	44.0 	46.6 	56.2 	55.7 	70.5 	78.7
Other non-operating income (expense) 	(78.3) 	(15.2) 	(14.4) 	(16.0) 	(18.4) 	(25.0) 	(32.9) 	(33.0)
Non-operating income (expense) 	32.6 	18.1 	10.5 	13.0 	23.2 	26.3 	50.9 	62.0
Income before income taxes 	1,095.2 	765.5 	647.6 	648.1 	839.8 	775.6 	748.5 	780.3
Income taxes 	258.8 	182.3 	152.8 	150.2 	198.2 	186.7 	174.3 	172.8
Net income 	836.4 	583.2 	494.8 	497.9 	641.6 	588.9 	574.2 	607.5
Less: net income (loss) attributable to NCI 	0.6 	- 	(0.2) 	0.8 	0.4 	0.3 	(0.2) 	-
Net Income Attributable to CME Group 	835.8 	583.2 	495.0 	497.1 	641.2 	588.6 	574.4 	607.5
Net Income Attributable to Common Shareholders of CME Group 	835.8 	583.2 	495.0 	497.1 	641.2 	588.6 	574.4 	595.7
Effective Tax Rate 	23.6% 	23.8% 	23.6% 	23.2% 	23.6% 	24.1% 	23.3% 	22.1%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	2.34 	1.63 	1.38 	1.39 	1.79 	1.64 	1.60 	1.66
Diluted EPS 	2.33 	1.63 	1.38 	1.39 	1.79 	1.64 	1.60 	1.66
Weighted Average Number of Shares:
Basic Common Shares 	357,524 	357,691 	357,791 	358,047 	358,147 	358,261 	358,363 	358,582
Diluted Common Shares 	358,455 	358,457 	358,590 	358,612 	358,817 	358,888 	358,988 	359,019
Preferred Sahres 	- 	- 	- 	- 	- 	- 	2,890

-- 2 of 2 --